H. Lee Moffitt Cancer Center And Research Institute
Clinical trials sponsored by H. Lee Moffitt Cancer Center And Research Institute, explained in plain language.
-
New combo shows promise in tough lung cancer
Disease control CompletedThis study tested whether adding the drug AZD1775 to standard chemotherapy (carboplatin and paclitaxel) helps people with advanced squamous cell lung cancer live longer without their cancer growing. 42 participants received the combination. The main goal was to see how long it to…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC
-
First human test of new engineered immune cell therapy for tough cancers
Disease control CompletedThis early-stage study tested the safety and highest tolerable dose of a new, genetically modified immune cell therapy called PRGN-3007 UltraCAR-T in adults with advanced blood cancers and triple-negative breast cancer. The main goal was to see how much of the treatment patients …
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New app-based program aims to ease chemo burden for pancreatic cancer patients
Symptom relief CompletedThis study tested a program called STRONG that provides nutrition advice and supportive care remotely to adults with pancreatic cancer who are receiving chemotherapy. The goal was to see if the program was easy to use and if patients liked it. 50 people took part, and the study c…
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated Apr 26, 2026 19:38 UTC